Files
Download
Download Full Text (451 KB)
Contents
- Minimally Invasive Component Separation Reduces Wound-Healing Complications from Abdominal Surgery: Component separation, a major advance in abdominal wall reconstruction, can prevent hernia recurrence in many patients
- Bevacizumab for Glioblastoma: Symptom Relief Proven, Overall Survival Benefit Being Studied-The antiangiogenic agent bevacizumab has been shown to prolong progression-free survival and ameliorate symptoms in patients with recurrent glioblastoma. However, it remains unknown whether bevacizumab should be used to treat newly diagnosed glioblastoma and whether bevacizumab prolongs the overall survival of patients with glioblastoma
- HOUSE CALL: Hospice Care- Patients and families have choices for care and comfort
- INBRIEF: Panobinostat Elicits Durable Response in Hodgkin Lymphoma
Creative Commons License
This work is licensed under a Creative Commons Attribution-Noncommercial-No Derivative Works 3.0 License.
Publication Date
6-1-2012
Publisher
The University of Texas MD Anderson Cancer Center
City
Houston, Texas
Disciplines
History of Science, Technology, and Medicine | Oncology
Recommended Citation
Bronson, Sarah and Deming, Stephanie, "OncoLog, Volume 57, Number 06, June 2012" (2012). OncoLog MD Anderson's Report to Physicians (All issues). 226.
https://openworks.mdanderson.org/oncolog/226
Conditions Governing Access
Open
